TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
Saved in:
| Title: | TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis. |
|---|---|
| Authors: | Chen L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Lin W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Zhang H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Geng S; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Le Z; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Wan F; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Huang Q; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Chen H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Liu X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Lu JJ; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Kong L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China. konglinjiang@163.com. |
| Source: | Cell death & disease [Cell Death Dis] 2024 Mar 01; Vol. 15 (3), pp. 178. Date of Electronic Publication: 2024 Mar 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-4889 |
|---|---|
| DOI: | 10.1038/s41419-024-06472-5 |
